STONKWHISPER
← Back to Intel
Insider ActivityMAZE

Bernstein Harold, President, R&D & CMO at Maze Therapeutics, Inc., sold $101K of MAZE

Updated Jun 14, 2026
Bernstein Harold President, R&D & CMO
Maze Therapeutics, Inc. · $MAZE
$101K Total Value
3,348 Shares Traded
$30.0585 Price / Share
300 Shares Owned After
2026-04-02 Filing Date

Transaction Details

InsiderBernstein Harold
TitlePresident, R&D & CMO
CompanyMaze Therapeutics, Inc.
TickerMAZE
Transaction TypeSale
Transaction Date2026-04-01
Shares Traded3,348
Price Per Share$30.0585
Total Value$101K
Filed Date2026-04-02
Accession Number0002050172-26-000019

Ownership Context

Shares Owned After Transaction300
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0002050172-26-000019

Other Insider Trades — MAZE

Other Trades by Bernstein Harold

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for MAZE — Maze Therapeutics, Inc. →

Track MAZE insider activity in real time on The Wire →

Get alerts when Bernstein Harold files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 14, 2026 at 07:19 UTC

Want real-time data? Access The Wire for live sentiment tracking.